Company
Every investor coverage indicates participated in a round Prestige Brands raised.
Companies Prestige Brands acquired or merged with, per published coverage. Buying a company is not investing in one: nothing here counts in the deals column.
Stories naming Prestige Brands. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Hydration Pharmaceuticals, which sells Hydralyte in North America, listed on the ASX, raising $17 million at 29 cents and closing 22.4% higher. Former Swisse executives hold key roles and large stakes.
Hydralyte's North American arm, run by former Swisse executives, has begun an institutional roadshow for a $17 million ASX listing planned for December, with BW Equities handling the raising.
Also BW Equities
Hydralyte has appointed BW Equities for a $5.15 million convertible note raise ahead of a planned ASX float, with board members Radek Sali and Adam Gregory having backed it through Light Warrior in 2017.